COVID-19 Vaccines in Children with Cow's Milk and Food Allergies

Lucia Liotti1, Annamaria Bianchi2, Paolo Bottau3

  • 1Department of Pediatrics, AOU Ospedali Riuniti Ancona, Presidio Ospedaliero di Alta Specializzazione "G. Salesi", 60100 Ancona, Italy.

Nutrients
|August 27, 2021
PubMed

Insights

Children with food allergies can safely receive COVID-19 vaccines. Current data show no higher risk for allergic reactions in these children compared to the general population, with proper medical supervision.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • The COVID-19 pandemic necessitates widespread vaccination for control.
  • Concerns exist regarding COVID-19 vaccine safety in allergic populations.
  • Post-marketing data have fueled debate on allergic reactions.

Purpose of the Study:

  • To assess the risk of allergic reactions to COVID-19 vaccines in children with food allergies.
  • To compare this risk against the general pediatric population.

Main Methods:

  • Review of current data and post-marketing surveillance findings.
  • Analysis of allergic reactions in children with a history of cow's milk or food allergy.

Main Results:

  • The risk of allergic reactions to COVID-19 vaccines is generally low.
  • Children with a history of food allergy, including severe cases, do not appear to be at a higher risk.
  • No increased incidence of anaphylaxis was observed in this specific group.

Conclusions:

  • COVID-19 vaccination is recommended for children with food allergies.
  • Vaccination should occur in a controlled medical setting with anaphylaxis management protocols.
  • A 30-minute observation period post-vaccination is advised for early detection of any adverse reactions.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Vaccinations01:51

Vaccinations

Overview
46.8K
Cross-reactivity00:42

Cross-reactivity

Overview
31.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
695
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55